Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping

Journal of Molecular Biology

Volumn 288, Issue 3, 1999, Pages 403-412

  Yang, Fan ^a   Bewley, Carole A ^b   Louis, John M ^b   Gustafson, Kirk R ^a   Boyd, Michael R ^a   Gronenborn, Angela M ^b   Clore, G Marius ^b   Wlodawer, Alexander ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cyanovirin N; Domain swapping; Human immunodeficiency virus; Protein structure; Virucides

Indexed keywords

ANTIVIRUS AGENT; CYANOVIRIN N; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIMERIZATION; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; VIRUS INACTIVATION;

EID: 0033532212     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2693     Document Type: Article

References (32)

1. Baldwin E. T., Weber I. T., St. Charles R., Xuan J.-C., Appella E., Yamada M., Matsushima K., Edwards B. F. P., Clore G. M., Gronenborn A. M., Wlodawer A. Crystal structure of interleukin-8: symbiosis of NMR and crystallography. Proc. Natl Acad. Sci. USA. 88:1991;502-506.
2. Bennett M. J., Eisenberg D. Refined structure of monomeric diphtheria toxin at 2.3 Å resolution. Protein Sci. 3:1994;1464-1475.
3. Bennett M. J., Schlunegger M. P., Eisenberg D. 3D domain swapping: a mechanism for oligomer assembly. Protein Sci. 4:1995;2455-2468.
4. Bewley C. A., Gustafson K. R., Boyd M. R., Covell D. G., Bax A., Clore G. M., Gronenborn A. M. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nature Struct. Biol. 5:1998;571-578.
5. Boyd M. R., Gustafson K. R., McMahon J. B., Shoemaker R. H., O'Keefe B. R., Mori T., Gulakowski R. J., Wu L., Rivera M. I., Laurencot C. M., Currens M. J., Cardellina J. H. II, Buckheit R. W. Jr., Nara P. L., Pannell L. K. et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus- inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41:1997;1521-1530.
6. Brünger A. T. The free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992a;472-474.
7. Brünger A. T. X-PLOR Version 3.1: A System for X-ray Crystallography and NMR. 1992b;Yale University Press, New Haven.
8. Brünger A. T., Adams P. D., Core G. M., DeLano W. L., Gros P., Grosse-Kunstleve R. W., Jiang J. S., Kuszewski J., Nilges M., Pannu N. S., Read R. J., Rice L. M., Simonson T., Warren G. L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect D. 54:1998;905-921.
9. Clore G. M., Gronenborn A. M. New methods of structure refinement for macromolecular structure determination by NMR. Proc. Natl Acad. Sci. USA. 95:1998;5891-5898.
10. Clore G. M., Gronenborn A. M., Szabo A., Tjandra N. Determining the magnitude of the fully asymmetric diffusion tensor from heteronuclear relaxation data in the absence of structural information. J. Am. Chem. Soc. 120:1998;4889-4890.
11. Crestfield A. M., Stein W. H., Moore S. On the aggregation of bovine pancreatic ribonuclease. Arch. Biochem. Biophys. 1962;217-222.
12. Duquerroy S., Le Bras G., Janin J. Lobster enolase crystallized by serendipity. Proteins: Struct. Funct. Genet. 18:1994;390-393.
13. Esser M. T., Mori T., Mondor I., Sattentau Q. J., Boyd M. R., Lifson J. D. Cyanovirin-N blocks HIV-1 binding and fusion but does not affect sCD4 induced conformational changes in gp120. J. Virol. 1999.
14. Gustafson K. R., Sowder R. C. II, Henderson L. E., Cardellina J. H. II, McMahon J. B., Rajamani U., Pannell L. K., Boyd M. R. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the cyanobacterium Nostoc ellipsosporum. Biochem. Biophys. Res. Commun. 238:1997;223-228.
15. Jones T. A., Kieldgaard M. Electron-density map interpretation. Methods Enzymol. 277:1997;173-208.
16. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
17. Mazzarella L., Capasso S., Demasi D., Di Lorenzo G., Mattia C. A., Zagari A. Bovine seminal ribonuclease: structure at 1.9 Å resolution. Acta Crystallog. sect. D. 49:1993;389-402.
18. Mori T., Shoemaker R. H., Gulakowski R. J., Krepps B. L., McMahon J. B., Gustafson K. R., Pannell L. K., Boyd M. R. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein. Biochem. Biophys. Res. Commun. 238:1997a;218-222.
19. Mori T., Shoemaker R. H., McMahon J. B., Gulakowski R. J., Gustafson K. R., Boyd M. R. Construction and enhanced cytotoxicity of a [cyanovirin-N]- [Pseudomonas exotoxin] conjugate against human immunodeficiency virus-infected cells. Biochem. Biophys. Res. Commun. 239:1997b;884-888.
20. Mori T., Gustafson K. R., Pannell L. K., Shoemaker R. H., Wu L., McMahon J. B., Boyd M. R. Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium. Protein Expr. Purif. 12:1998;151-158.
21. Navaza J. An automated package for molecular replacement. Acta Crystallog. sect A. 50:1994;157-163.
22. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
23. Parge H. E., Arvai A. S., Murtari D. J., Reed S. I., Tainer J. A. Human CksHs2 atomic structure: a role for its hexameric assembly in cell cycle control. Science. 262:1993;387-395.
24. Piccoli R., Tamburrini M., Piccialli G., Di Donato A., Parente A., D'Alessio G. The dual-mode quarternary structure of seminal RNase. Proc. Natl Acad. Sci. USA. 89:1992;1870-1874.
25. Rozwarski D. A., Gronenborn A. M., Clore G. M., Bazan J. F., Bohm A., Wlodawer A., Hatada M., Karplus P. A. Structural comparisons among the short-chain helical cytokines. Structure. 2:1994;159-173.
26. Schlunegger M. P., Bennett M. J., Eisenberg D. Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly. Advan. Protein Chem. 50:1997;61-122.
27. Sheldrick G. M., Schneider T. R. SHELXL: high-resolution refinement. Methods Enzymol. 277:1997;319-343.
28. 15N NMR relaxation measurements at two magnetic fields. J. Biomol. NMR. 8:1996;273-284.
29. 13C couplings in the structure determination of magnetically oriented macromolecules in solution. Nature Struct. Biol. 4:1997;732-738.
30. Wlodawer A., Hodgson K. O. Crystallization and crystal data of monellin. Proc. Natl Acad. Sci. USA. 72:1975;398-399.
31. Xu D., Tsai C.-J., Nussinov R. Mechanism and evolution of protein dimerization. Protein Sci. 7:1998;533-544.
32. Zdanov A., Schalk-Hihi C., Gustchina A., Tsang M., Weatherbee J., Wlodawer A. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure. 3:1995;591-601.